Improving health outcomes while combating homelessness
Beth Sandor of Community Solutions discusses a pilot program in which health systems partnered with organizations in their communities fighting homelessness.
November policy roundup with Nick Hut and Shawn Stack
Senior Editor Nick Hut and HFMA Policy Director Shawn Stack discuss the latest in healthcare finance news.
Healthcare Blame Game: Bigger may prove to be better in healthcare, despite critics’ take
Brad talks with Susan Dentzer, president and CEO of America’s Physician Groups, about why healthcare consolidation is more nuanced than critics understand.
Humans are essential to your AI strategy
Arun Shastri of ZS discusses uses for AI in healthcare as well as the limitations of technology when a human isn't involved.
The best care starts with the patient
Rami Karjian and Pippa Shulman from Medically Home discuss why higher payment and lower length of stay isn't always the best benchmark.
It starts with mental health: How caring for transgender youth makes for healthier adults
Rodrigo Heng-Lehtinen, executive director for the National Center for Transgender Equality, returns to the podcast to discuss the misconceptions around transition-related care for young people.
The intersection of quality and finance, with Rick Gundling and Stephanie Mercado
HFMA's Rick Gundling and Stephanie Mercado from the National Association for Healthcare Quality discuss how all entities within a healthcare organization can work for better quality.
The future of healthcare transparency, with Nick Hut and Andrew Donahue
HFMA Senior Editor Nick Hut and HFMA Policy Director Andrew Donohue discuss legislative action that could affect transparency efforts in healthcare.
Fighting for systemic change by putting the patient first
Rami Karjian and Raphael Rakowski of Medically Home discuss emphasizing patients over all else in healthcare, and Julie Lambert and Lori Zindl from Inovalon talk about an RCM survey.
Dr. Ronald Hirsch of R1 RCM discusses new Alzheimer’s drug Leqembi with HFMA’s Nick Hut
Dr. Ronald Hirsch of R1RCM discusses considerations around a new Alzheimer's drug with Senior Editor Nick Hut.